In recent years, two existing drugs—Ivermectin and Mebendazole—have captured the attention of researchers and healthcare professionals alike for their potential anti-cancer effects. As the quest for non-chemotherapy, non-radiation therapies advances, understanding how these drugs could reshape cancer treatment is becoming increasingly vital. This article delves into the science behind IVM and MBZ, illuminating their mechanisms, available research, and the promise they hold for the future of oncology.
Courage Against Cancer 